logo
French left urges Macron to act over US plan to destroy contraceptives

French left urges Macron to act over US plan to destroy contraceptives

Yahoo3 days ago
France's left-wing politicians on Saturday called on President Emmanuel Macron to intervene over US plans to destroy nearly $10 million worth of female contraceptives in Europe, calling it an "affront" to public health.
A State Department spokesperson told AFP this week that "a preliminary decision was made to destroy certain" birth control products from "terminated Biden-era USAID contracts."
The US Agency for International Development, the country's foreign aid arm, was dismantled by Donald Trump's administration when he returned to office in January, replacing former president Joe Biden.
Under the plan, some $9.7 million worth of implant and IUD contraceptives stored in Belgium are reportedly set to be incinerated in France.
An open letter signed by French Green leader Marine Tondelier and several female lawmakers called the US decision "an affront to the fundamental principles of solidarity, public health and sexual and reproductive rights that France is committed to defending."
In the letter, they urged the French president "not to be complicit, even indirectly, in retrograde policies," saying women's contraception products such as IUDs and implants were intended for "low- and middle-income countries."
"Cutting aid for contraception is shameful, destroying products that have already been manufactured and financed is even more mind-boggling," Tondelier told AFP.
The Greens urged Macron to request the suspension of the plan "as part of a joint initiative with the European Commission."
They also called on him to back humanitarian organisations that say they are ready to redistribute the contraception products.
Separately, Mathilde Panot, parliamentary leader of the hard left France Unbowed (LFI) party, also urged Macron and Prime Minister Francois Bayrou to take action.
"You have a responsibility to act to prevent this destruction, which will cost lives," she said on X.
"These resources are vital, particularly for the 218 million women who do not have access to contraceptive care."
The US plan has sparked outrage from global health NGOs, with Doctors Without Borders denouncing the "callous waste."
"It is unconscionable to think of these health products being burned when the demand for them globally is so great," said Rachel Milkovich of the medical charity's US office.
The State Department spokesperson said the destruction will cost $167,000 and "no HIV medications or condoms are being destroyed."
Doctors Without Borders says that other organisations have offered to cover the shipping and distribution costs of the supplies, but the US government declined to sign off.
US lawmakers have approved slashing some $9 billion in aid primarily destined for foreign countries.
sde-ama-as/ach
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche

Yahoo

time22 minutes ago

  • Yahoo

Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche

The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed nations, have embraced HPV-based screenings, driving demand. However, challenges such as limited access and high technology costs in low-income countries remain. Notable market segments include consumables, immunodiagnostics, and PCR testing. Key regions like the U.S., France, India, and Saudi Arabia see varied growth based on governmental support, awareness, and infrastructure. Human Papilloma Virus Testing Market Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "Human Papilloma Virus Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to Human papillomavirus (HPV) Testing Market was USD 1.52 billion in 2024 and is expected to reach USD 3.62 billion by 2033, with a CAGR of 10.11% from 2025 to 2033. The growth is due to increasing awareness of cervical cancer, increased screening programs, and technological advancements in diagnostic technologies in global healthcare systems. Internationally, the use of HPV testing is increasing with growing awareness regarding prevention of cervical cancer, government-sponsored screening programs, and WHO's initiative to eliminate cervical cancer as a public health issue. Developed countries have embraced HPV-based screening on a large scale, and developing nations are also adopting it, with the support of global health programs. Its high sensitivity and long-term risk prediction make it a method of choice in contemporary gynecological Driver in the Human Papilloma Virus (HPV) Testing Market Increasing Awareness and Government Screening ProgramsInternational awareness programs and country-level screening programs have increased demand for HPV testing to a large extent. Governments in developed and emerging economies are adopting routine cervical cancer screening guidelines for women aged 30 and older. WHO organizations advocate for HPV testing as a key tool for early detection of cancer. Greater awareness of HPV-associated cancers and immunization also reinforces demand. These efforts account for early diagnosis, prompt intervention, and overall reduction in HPV-associated disease burden, thus driving the market forward. SEP 2024, The United States, Australia, India, and Japan are rolling out a key initiative to fight cervical cancer across the Indo-Pacific, a preventable disease which is a significant health crisis in the region. This initiative is part of larger announcements made during the Quad Leaders Breakthroughs in HPV TestingInnovation in diagnostic methods - like PCR, next-generation sequencing, and self-sampling kits - has revolutionized HPV testing by enhancing accuracy, accessibility, and convenience. Automated platforms, multiplex assays, and liquid-based cytology enable quicker turnaround times and large-scale screening. These technologies are particularly precious in resource-poor settings and enable wider adoption in public health systems. Ongoing R&D spending by diagnostic firms serves to improve test sensitivity and affordability, fueling additional market growth. June 2023, The WHO has prequalified a fourth test for human papillomavirus (HPV). Although most HPV infections will clear on their own, a few of the higher-risk types can cause cervical cancer, so HPV testing is important for cervical cancer Prevalence of HPV-Associated Cancers Growing global incidence of HPV-related cancers, particularly cervical cancer, is a strong market driver. Cervical cancer is the fourth leading female cancer in the world according to the WHO, and the overwhelming majority of cases are caused by high-risk HPV types. Growing cases of cancer have driven the need for early detection strategies, putting HPV testing at the center of preventive medicine. As healthcare professionals and patients strive for surefire diagnostic measures, HPV testing is also becoming a necessity in women's health care. An estimated 47,984 new cases of cancer occur each year in the United States in areas of the body where human papillomavirus (HPV) commonly in the Human Papilloma Virus (HPV) Testing Market Limited Access in Low-Income CountriesIn spite of worldwide awareness, HPV testing is not readily available in low- and middle-income countries because of a lack of healthcare infrastructure and resources. There are few laboratory facilities, skilled professionals, and regular screening programs in most areas. Cultural taboo and sexual stigma also discourage HPV testing participation. This inequality avoids early diagnosis and enhances the risk of cervical cancer at advanced stages. It is essential to overcome these barriers using cost-effective point-of-care diagnostics and education initiatives for equitable market Cost of Sophisticated HPV Testing TechnologiesThe price of advanced HPV testing technologies, including PCR-based platforms and DNA sequencing, can be out of reach for healthcare systems and some patients. As developed nations implement these technologies into regular screening, the affordability gap restricts accessibility in resource-scarce settings. In addition, maintenance costs, quality assurance, and specialized staff requirements contribute to higher operating costs for clinics and laboratories. This cost factor hinders mass screening activities, particularly in developing countries. Key Players Analyzed: Overview, Key Persons, Recent Development & Strategies, Financial Insights Abbott Laboratories BioMerieux SA Bio-Rad Laboratories, Inc. Epigenomics AG Siemens Healthineers AG Hologic Inc Qiagen NV F. Hoffmann-La Roche Ltd Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $1.52 Billion Forecasted Market Value (USD) by 2033 $3.62 Billion Compound Annual Growth Rate 10.1% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Human Papilloma Virus Testing Market5.1 Historical Market Trends5.2 Market Forecast6. Human Papilloma Virus Testing Market Share Analysis6.1 By Application6.2 By Product6.3 By Technology6.4 By End Use6.5 By Countries7. Application7.1 Cervical Cancer Screening7.2 Vaginal Cancer Screening8. Product8.1 Consumables8.2 Instruments8.3 Services9. Technology9.1 Polymerase chain reaction (PCR)9.2 Liquid-based cytology9.3 Immunodiagnostics9.4 Hybrid Capture9.5 Others10. End Use10.1 Hospitals & Clinics10.2 Laboratories10.3 Others11. Countries11.1 North America11.1.1 United States11.1.2 Canada11.2 Europe11.2.1 France11.2.2 Germany11.2.3 Italy11.2.4 Spain11.2.5 United Kingdom11.2.6 Belgium11.2.7 Netherlands11.2.8 Turkey11.3 Asia-Pacific11.3.1 China11.3.2 Japan11.3.3 India11.3.4 South Korea11.3.5 Thailand11.3.6 Malaysia11.3.7 Indonesia11.3.8 Australia11.3.9 New Zealand11.4 Latin America11.4.1 Brazil11.4.2 Mexico11.4.3 Argentina11.5 Middle East & Africa11.5.1 Saudi Arabia11.5.2 UAE11.5.3 South Africa12. Porter's Five Forces Analysis12.1 Bargaining Power of Buyers12.2 Bargaining Power of Suppliers12.3 Degree of Rivalry12.4 Threat of New Entrants12.5 Threat of Substitutes13. SWOT Analysis13.1 Strength13.2 Weakness13.3 Opportunity13.4 Threat 14. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Human Papilloma Virus Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Melden Sie sich an, um Ihr Portfolio aufzurufen.

Minister accuses Farage of being on side of ‘pornographers' in online safety row
Minister accuses Farage of being on side of ‘pornographers' in online safety row

Yahoo

time22 minutes ago

  • Yahoo

Minister accuses Farage of being on side of ‘pornographers' in online safety row

A row has broken out between Labour and Reform after the Technology Secretary accused Nigel Farage of being on the side of 'extreme pornographers' and 'Jimmy Savile' over his party's pledge to scrap the Online Safety Act. Mr Farage labelled the comments 'disgusting' and called on Peter Kyle to apologise, after the Cabinet minister said the Reform leader is 'on the side of turning the clock back' to when 'strangers can get in touch via messaging apps with children'. Former Reform chairman Zia Yusuf claimed the remarks are 'one of the most outrageous and disgusting things apolitician has said in the political arena'. Under rules that came into effect on July 25, online platforms such as social media sites and search engines must take steps to prevent children accessing harmful content such as pornography or material that encourages suicide. Mr Yusuf said on Monday that the party would repeal the legislation if they got into Government, claiming it works to 'suppress freedom of speech' and 'force social media companies to censor anti-government speech'. Speaking to Sky News on Tuesday, Mr Kyle said that children have been living in a 'wild west' and labelled the new law 'a big step forward'. He added: 'I see that Nigel Farage is already saying that he's going to overturn these laws. So you know, we have people out there who are extreme pornographers, peddling hate, peddling violence. Nigel Farage is on their side. 'Make no mistake about it, if people like Jimmy Savile were alive today, he'd be perpetrating his crimes online. And Nigel Farage is saying that he's on their side.' Asked to clarify his comments, Mr Kyle said: 'Nigel Farage is on the side of turning the clock back to the time when strange adults, strangers can get in touch via messaging apps with children.' Mr Farage reacted on X by calling Mr Kyle's remarks 'disgusting' and said 'he should do the right thing and apologise'. Mr Kyle then doubled down on his comments in response, and said that 'if you want to overturn the Online Safety Act you are on the side of predators. It is as simple as that.' Mr Yusuf claimed that Mr Kyle's remarks showed 'how deeply unserious' the Government was about child safety, adding: 'Talking about Jimmy Savile in that way does nothing other than denigrate the victims of Jimmy Savile.' He told Sky News that the comments are 'one of the most outrageous and disgusting things a politician has said in the political arena that I can remember. And that's quite a high bar, frankly.' Sir Keir Starmer jumped to defend the legislation from its critics when he met Donald Trump on Monday, telling reporters 'We're not censoring anyone'. 'We've got some measures which are there to protect children, in particular, from sites like suicide sites.' He added: 'I personally feel very strongly that we should protect our young teenagers, and that's what it usually is, from things like suicide sites. I don't see that as a free speech issue, I see that as child protection.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store